Rituximab (anti-CD20)

目录号：A2009         批次号: A200906

打印

Rituximab (anti-CD20)是嵌合的anti-CD20单克隆抗体，与B细胞上的CD20抗原结合，结合亲和力为5 nM。MW: 143.86 KD。

抗体信息

CAS号 174722-31-7
配制 PBS buffer, pH 7.2
推荐同型对照 Human IgG1
来源 CHO cells
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
纯度 98.89%
蛋白浓度 8.65mg/ml
内毒素 ＜1EU/mg

Rituximab (anti-CD20)在文献中得到引用

Distinct CD16a features on human NK cells observed by flow cytometry correlate with increased ADCC [ Sci Rep, 2024, 14(1):7938] PubMed: 38575779
Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab [ Am J Nucl Med Mol Imaging, 2024, 14(1):31-40] PubMed: 38500749
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease [ Oncoimmunology, 2023, 12(1):2163784] PubMed: 36632565
Development and implementation of natural killer cell simultaneous ADCC and direct killing assay [ Heliyon, 2023, 9(12):e22991] PubMed: 38125417
Rheumatoid factor IgM autoantibodies control IgG homeostasis [ Front Immunol, 2022, 13:1016263] PubMed: 36341420
Beta-Lapachone Attenuates BMSC-Mediated Neuroblastoma Malignant Transformation by Inhibiting Gal-3/Gal-3BP/IL6 Axis [ J Pharmacol Exp Ther, 2022, 381(1):12-21] PubMed: 35078863
A versatile platform for the tumor-targeted delivery of immune checkpoint-blocking immunoglobin G [ J Control Release, 2021, 340:243-258] PubMed: 34752799
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors [ Blood Adv, 2021, 5(10):2467-2480] PubMed: 33999145
Salt-dependent passive adsorption of IgG1κ-type monoclonal antibodies on hydrophobic microparticles [ Biophys Chem, 2021, 275:106609] PubMed: 33975078
Tumor-Targeting Liposomes with Transient Holes Allowing Intact Rituximab Internally [ Biomacromolecules, 2020, 22(2):723-731] PubMed: 33280388

禁止用于人体及治疗！